ABT Abbott Laboratories Forecast, Technical & Fundamental Analysis

ABT in -2.15% downward trend, declining for three consecutive days on September 10, 2025

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where ABT declined for three days, in of 269 cases, the price declined further within the following month. The odds of a continued downward trend are .

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 16, 2025. You may want to consider a long position or call options on ABT as a result. In of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ABT just turned positive on September 17, 2025. Looking at past instances where ABT's MACD turned positive, the stock continued to rise in of 55 cases over the following month. The odds of a continued upward trend are .

ABT moved above its 50-day moving average on September 11, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for ABT crossed bullishly above the 50-day moving average on August 18, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ABT advanced for three days, in of 319 cases, the price rose further within the following month. The odds of a continued upward trend are .

ABT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 313 cases where ABT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.619) is normal, around the industry mean (60.147). P/E Ratio (16.834) is within average values for comparable stocks, (37.952). Projected Growth (PEG Ratio) (2.271) is also within normal values, averaging (1.606). Dividend Yield (0.017) settles around the average of (0.019) among similar stocks. P/S Ratio (5.438) is also within normal values, averaging (81.192).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ABT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock slightly better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.